Recursion Pharmaceuticals: Q1 Earnings Snapshot

Published: 2026-05-06 06:37:08 ET RXRX

Published on 05/06/2026 at 06:37 am EDT

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $117.5 million in its first quarter.

The Salt Lake City-based company said it had a loss of 22 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

The biotechnology company posted revenue of $6.5 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $16.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News